Paul A Rufo

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations
    Paul A Rufo
    Center for Inflammatory Bowel Disease, Children s Hospital Boston, Boston, MA 02115, USA
    J Pediatr Gastroenterol Nutr 55:93-108. 2012
  2. ncbi request reprint Current therapy of inflammatory bowel disease in children
    Paul A Rufo
    Center for Inflammatory Bowel Diseases, Combined Program in Gastroenterology and Nutrition, Children s Hospital, Boston, Massachusetts 02115, USA
    Paediatr Drugs 8:279-302. 2006
  3. ncbi request reprint Challenges and progress in pediatric inflammatory bowel disease
    Paul A Rufo
    Children s Hospital Boston, Inflammatory Bowel Disease Center, Boston, Massachusetts 02115, USA
    Curr Opin Gastroenterol 23:406-12. 2007
  4. ncbi request reprint Diarrhea-associated HIV-1 APIs potentiate muscarinic activation of Cl- secretion by T84 cells via prolongation of cytosolic Ca2+ signaling
    Paul A Rufo
    GI Cell Biology, Combined Program in Pediatric Gastroenterology and Nutrition, Children s Hospital, 300 Longwood Ave, Boston, MA 02115, USA
    Am J Physiol Cell Physiol 286:C998-C1008. 2004
  5. ncbi request reprint Pancreatitis as the initial manifestation of stage IV neuroblastoma
    Douglas S Fishman
    Division of Pediatric Gastroenterology and Nutrition, Children s Hospital, Boston, MA 02115, USA
    J Pediatr Gastroenterol Nutr 44:146-8. 2007
  6. doi request reprint Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease
    Michael A Manfredi
    Center for Inflammatory Bowel Disease, Children s Hospital, Boston, Massachusetts, USA
    Inflamm Bowel Dis 14:1091-6. 2008
  7. ncbi request reprint Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease
    Thomas R Walker
    Center for Inflammatory Bowel Disease, Harvard Medical School, Boston, MA, USA
    J Pediatr Gastroenterol Nutr 44:414-22. 2007
  8. ncbi request reprint Severe colitis in children
    Subra Kugathasan
    Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    J Pediatr Gastroenterol Nutr 41:375-85. 2005
  9. ncbi request reprint Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation
    Sunanda V Kane
    University of Chicago, Chicago, Illinois 60637, USA
    Am J Gastroenterol 98:1309-14. 2003

Research Grants

Collaborators

Detail Information

Publications9

  1. doi request reprint Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations
    Paul A Rufo
    Center for Inflammatory Bowel Disease, Children s Hospital Boston, Boston, MA 02115, USA
    J Pediatr Gastroenterol Nutr 55:93-108. 2012
    ....
  2. ncbi request reprint Current therapy of inflammatory bowel disease in children
    Paul A Rufo
    Center for Inflammatory Bowel Diseases, Combined Program in Gastroenterology and Nutrition, Children s Hospital, Boston, Massachusetts 02115, USA
    Paediatr Drugs 8:279-302. 2006
    ..In addition, patients with UC and CD involving the colon are at increased risk of developing colon cancer, and should be enrolled into a colonoscopy surveillance program after 8-10 years of disease duration...
  3. ncbi request reprint Challenges and progress in pediatric inflammatory bowel disease
    Paul A Rufo
    Children s Hospital Boston, Inflammatory Bowel Disease Center, Boston, Massachusetts 02115, USA
    Curr Opin Gastroenterol 23:406-12. 2007
    ....
  4. ncbi request reprint Diarrhea-associated HIV-1 APIs potentiate muscarinic activation of Cl- secretion by T84 cells via prolongation of cytosolic Ca2+ signaling
    Paul A Rufo
    GI Cell Biology, Combined Program in Pediatric Gastroenterology and Nutrition, Children s Hospital, 300 Longwood Ave, Boston, MA 02115, USA
    Am J Physiol Cell Physiol 286:C998-C1008. 2004
    ..These data show that APIs modulate Ca(2+) signaling in secretory epithelial cells and identify a novel target for treatment of clinically important API side effects...
  5. ncbi request reprint Pancreatitis as the initial manifestation of stage IV neuroblastoma
    Douglas S Fishman
    Division of Pediatric Gastroenterology and Nutrition, Children s Hospital, Boston, MA 02115, USA
    J Pediatr Gastroenterol Nutr 44:146-8. 2007
  6. doi request reprint Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease
    Michael A Manfredi
    Center for Inflammatory Bowel Disease, Children s Hospital, Boston, Massachusetts, USA
    Inflamm Bowel Dis 14:1091-6. 2008
    ..We previously demonstrated that elevated urinary MMP levels are independent predictors of disease status in cancer patients. Here we demonstrate that elevated urinary MMP levels may be biomarkers of disease activity in patients with IBD...
  7. ncbi request reprint Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease
    Thomas R Walker
    Center for Inflammatory Bowel Disease, Harvard Medical School, Boston, MA, USA
    J Pediatr Gastroenterol Nutr 44:414-22. 2007
    ..We further assessed the relationship between FLA levels and customary laboratory and clinical measures of inflammation...
  8. ncbi request reprint Severe colitis in children
    Subra Kugathasan
    Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    J Pediatr Gastroenterol Nutr 41:375-85. 2005
  9. ncbi request reprint Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation
    Sunanda V Kane
    University of Chicago, Chicago, Illinois 60637, USA
    Am J Gastroenterol 98:1309-14. 2003
    ..The aim of this study was to determine the sensitivity and specificity of fecal lactoferrin concentrations for inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) versus healthy controls...

Research Grants2

  1. CLOTRIMAZOLE THERAPY FOR HUMAN DIARRHEAL DISEASES
    PAUL RUFO; Fiscal Year: 2003
    ..To receive formal training in biostatistics, epidemiology, and research ethics, Dr. Rufo will complete a Masters of Medical Sciences degree program at Harvard Medical School. ..
  2. CLOTRIMAZOLE ENEMAS FOR POUCHITIS IN CHILDREN AND ADULTS
    PAUL RUFO; Fiscal Year: 2005
    ..Abstract Not Provided ..